Overview

Comparative Pharmacodynamics and Pharmacodynamics Equivalence of Antareit 800 mg/10 ml Oral Suspension and Riopan 800 mg Chewable Tablets in Healthy Volunteers

Status:
Not yet recruiting
Trial end date:
2025-09-20
Target enrollment:
Participant gender:
Summary
Comparative study of the pharmacodynamic parameters and pharmacodynamic equivalence (bioequivalence) of drug Antareit 800 mg/10 ml oral suspension and drug Riopan 800 mg chewable tablets in healthy volunteers.
Phase:
N/A
Details
Lead Sponsor:
Valenta Pharm JSC